Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get all the relevant market information you need — get it fast, on time, and accurately with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Pharming Group N.V. ADR (PHAR)

Pharming Group N.V. ADR (PHAR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Pharming Group N.V. ADR DARWINWEG 24 LEIDEN P7 2333 CR NLD

www.pharming.com Employees: 404 P: 31-71-524-7400 F: +31 715247445

Sector:

Medical

Description:

Pharming Group N.V. is a commercial stage biopharmaceutical company. It engages in developing protein replacement therapies and precision medicines for the treatment of rare diseases and unmet medical needs. The company's product portfolio includes C1INH. Pharming Group N.V. is based in Leiden, The Netherlands.

Key Statistics

Overview:

Market Capitalization, $K 1,122,941
Enterprise Value, $K 982,211
Shares Outstanding, K 70,140
Float, K 68,688
% Float 97.93%
Short Interest, K 15
Short Float 0.02%
Days to Cover 1.00
Short Volume Ratio 0.85
% of Insider Shareholders 2.07%
% of Institutional Shareholders 0.03%

Financials:

Annual Sales, $ 376,130 K
Annual Net Income, $ 2,850 K
Last Quarter Sales, $ 106,500 K
Last Quarter Net Income, $ 5,300 K
EBIT, $ 25,850 K
EBITDA, $ 37,070 K

Growth:

1-Year Return 100.24%
3-Year Return 34.42%
5-Year Return 20.76%
5-Year Revenue Growth 77.32%
5-Year Earnings Growth -93.10%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings 0.07 on 03/12/26
Next Earnings Date 05/14/26
Earnings Per Share ttm 0.01
EPS Growth vs. Prev Qtr -30.00%
EPS Growth vs. Prev Year 40.00%
Annual Dividend & Yield (Paid) 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%

PHAR Ratios

Ratio
Price/Earnings ttm 1,631.00
Price/Earnings forward 43.49
Price/Earnings to Growth N/A
Return-on-Equity % 1.08%
Return-on-Assets % 0.59%
Profit Margin % 0.76%
Debt/Equity 0.02
Price/Sales 3.04
Price/Cash Flow 81.32
Price/Book 4.13
Book Value/Share 3.95
Interest Coverage -1.06
60-Month Beta 0.04
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.